HOME >> BIOLOGY >> NEWS
JCI table of contents, November 15 2004

New gene mutation found to cause "bubble boy disease"

Approximately one in every million people develop a group of inherited disorders known as severe combined immunodeficiency (SCID) or "bubble boy disease". Characterized by inherited abnormal changes in B and T cells of their immune system, these individuals often suffer from numerous serious or life-threatening infections that are often fatal in early life. The condition became widely known in the 1970's when the world learned of David Vetter, a boy with SCID who lived for 12 years in a plastic, germ-free bubble.

A number of genetic abnormalities can cause SCID. The two most common forms are linked to the X chromosome. Patients with abnormalities on this chromosome either lack an enzyme called adenosine deaminase, or lack the ability to produce IL-2 receptor gamma chain, a molecule that T cells need to communicate with B cells. In some cases of SCID, doctors have been unable to identify the underlying cause.

In the November 15 issue of the Journal of Clinical Investigation, Franoise Le Deist and colleagues from INSERM, Paris, describe how a complete deficiency in the CD3 epsilon chain of the T cell receptor, which binds foreign antigens and thus targets them for destruction, causes SCID.

The authors studied 3 families with, or having had lost, infants with SCID of an unknown molecular type. All of these individuals had normal B cells but no T cells. The authors found that the absence of CD3 epsilon completely blocks T cell development at a specific stage in the thymus.

In an accompanying commentary, Rebecca H. Buckley, a pediatrician at Duke University Medical Center, discusses the importance of the identification of this new mutation. "If the diagnosis is made at birth or shortly thereafter, definitive therapy in the form of bone marrow stem cell transplantation can result in a survival rate as high as 97%, regardless of the molecular type of SCID."
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
15-Nov-2004


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/27/2020)... ... 2020 , ... On Thursday, February 20, 2020 at 10am EST (3pm GMT/UK), ... and Richard Castle, Global Account Manager Medical Device at PRISYM ID for ... MDR timing deadlines, best practices in creating and submitting product data and best practices ...
(Date:1/24/2020)... ... January 24, 2020 , ... The Rockies Venture Club ... to support early-stage bioscience companies in the state. , “Colorado has ... the funding they need to innovate and grow. This program will mobilize ...
(Date:1/23/2020)... ... 23, 2020 , ... GIOSTAR/HEAMGEN has developed and ... The red blood cells are made utilizing a bioreactor that permits the ... and replaces the need for a human blood donor. GIOSTAR/HEAMGEN mature ...
Breaking Biology News(10 mins):
(Date:1/24/2020)... ... 24, 2020 , ... Sierra Instruments, global leader in mass ... ideal for BioPharm OEMS. Sierra also announces RedyCompact™ flow meters ... employ high-precision MEMS (Micro-Electro Mechanical Systems) technology utilizing an advanced, ultra-stable no-drift CMOS ...
(Date:1/22/2020)... ... January 21, 2020 , ... Microbial Discovery Group LLC (MDG) ... Industrial and Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s partners ... over 30 years of sales experience working across multiple different market sectors such ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new ... benchmarks for the vendor qualification process, a critical element of clinical trial set ... complexity of the vendor qualification process creates delays in initiation in 7% of ...
(Date:1/8/2020)... ... 2020 , ... Anomet Products has introduced new ... in harsh environments inside or outside of the human body. , ... to achieve specific properties such as corrosion-resistance, biocompatibility, or operation at temperatures from ...
Breaking Biology Technology:
Cached News: